|
|
||||||||
|
FIGURE 1. (A) Upper and lower panels represent transverse CT, SPECT, and hematoxylin and eosin histology of somatostatin receptor (SSR)-positive tumor 2 and SSR-negative tumor 1, respectively, in patient 1, after 4 cycles of PRRT. (B) Sizes of 4 hepatic lesions after PRRT with somatostatin analog (
). Tumors above stippled line were not seen on octreotide scan, nor were the 2 tumors below this line; one of each was biopsied and depicted in (A).
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY | THE JOURNAL OF NUCLEAR MEDICINE |